#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15654	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2256	689.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1464	1464	C	876	C,G,A	837,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28562	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3520	807.9	0	.	n	.	0	T695C	SNP	695	695	T	984	984	C	874	C,A	819,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28562	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3520	807.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1626	1626	A	908	A,G	859,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28562	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3520	807.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2260	2260	C	907	C,T	855,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28562	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3520	807.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2886	2886	T	851	T,C	814,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28562	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3520	807.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2334	2334	A	873	A	836	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	V36A	NONSYN	106	108	GTG	595	597	GCG	172;173;176	G;C;G	168;168;172	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	637	639	CGG	176;176;175	C;G;G	171;171;166	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	S68L	NONSYN	202	204	TCG	691	693	TTG	158;157;160	T,C;T,C;G	147,1;151,1;156	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	A90V	NONSYN	268	270	GCG	757	759	GTT	131;129;128	G;T;T	126;121;121	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	I105V	NONSYN	313	315	ATT	802	804	GTT	136;135;137	G,C;T;T	129,1;123;128	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	N125T	NONSYN	373	375	AAT	862	864	ACC	157;158;157	A;C;C	143;148;146	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	R135C	NONSYN	403	405	CGT	892	894	TGT	156;156;155	T;G;T	135;139;135	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	K151E	NONSYN	451	453	AAA	940	942	GAA	141;141;140	G;A;A	134;134;133	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	T152N	NONSYN	454	456	ACC	943	945	AAC	140;141;144	A;A;C	134;135;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	A172T	NONSYN	514	516	GCG	1003	1005	ACA	138;138;139	A;C;A	133;135;131	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	A175E	NONSYN	523	525	GCG	1012	1014	GAA	145;146;144	G;A;A	140;143;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	E176T	NONSYN	526	528	GAA	1015	1017	ACC	141;139;140	A;C;C	132;135;136	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	I178V	NONSYN	532	534	ATC	1021	1023	GTC	137;139;139	G;T;C	132;133;133	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1051	1053	ACG	150;149;148	A;C;G	142;141;139	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1087	1089	AAC	144;143;145	A;A;C	135;136;138	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1147	1149	TTG	157;155;157	T;T;G	144;141;143	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1204	1206	ACC	148;149;148	A;C;C	136;141;140	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1207	1209	GAC	150;151;148	G,A;A;C	140,1;139;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1216	1218	GCG	145;145;146	G,A,T;C,T;G	135,1,1;112,1;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1252	1254	GCT	131;130;134	G;C;T	118;116;118	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1582	folP	858	858	91.61	folP.l6.c4.ctg.1	1682	93.6	1	SNP	p	R230S	1	.	.	688	690	AGC	1177	1179	AGC	173;173;171	A;G;C	163;162;156	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4870	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3421	142.0	1	SNP	p	S91F	0	.	.	271	273	TCC	599	601	TCC	143;141;143	T;C,T;C,T	136;131,1;134,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4870	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3421	142.0	1	SNP	p	D95G	0	.	.	283	285	GAC	611	613	GAC	142;146;150	G;A,G;C	134;133,1;138	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4870	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3421	142.0	1	SNP	p	D95N	0	.	.	283	285	GAC	611	613	GAC	142;146;150	G;A,G;C	134;133,1;138	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1600	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1408	113.5	1	SNP	p	G45D	1	.	.	133	135	GAC	499	501	GAC	214;214;216	G;A;C	204;200;204	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	776	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1056	73.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5174	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2975	173.0	1	SNP	p	D86N	0	.	.	256	258	GAC	612	614	GAC	216;215;216	G,A;A;C	207,1;206;208	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5174	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2975	173.0	1	SNP	p	S87R	0	.	.	259	261	AGT	615	617	AGT	218;218;218	A;G,A;T	209;209,1;209	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5174	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2975	173.0	1	SNP	p	S87I	0	.	.	259	261	AGT	615	617	AGT	218;218;218	A;G,A;T	209;209,1;209	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5174	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2975	173.0	1	SNP	p	S87W	0	.	.	259	261	AGT	615	617	AGT	218;218;218	A;G,A;T	209;209,1;209	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5174	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2975	173.0	1	SNP	p	S88P	0	.	.	262	264	TCC	618	620	TCC	218;219;218	T;C;C,A	209;211;207,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4140	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2738	150.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1510	1512	GGC	217;209;205	G;G;C	203;195;190	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1329	1331	GCA	205;205;202	G;C;A	198;198;194	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1332	1334	ATC	205;207;205	A,G;T;C	192,1;199;195	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1344	1346	GTG	205;209;212	G;T;G	197;200;201	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1344	1346	GTG	205;209;212	G;T;G	197;200;201	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1848	1850	ACC	199;197;195	A;C;C,G	184;187;185,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1902	1904	GCG	183;185;184	G;C;G	162;151;156	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1902	1904	GCG	183;185;184	G;C;G	162;151;156	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2025	2027	GGC	152;151;150	G;G;C	143;137;141	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2034	2036	GGC	151;149;149	G;G;C	136;135;140	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2481	155.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2052	2054	CCG	129;130;129	C,G;C;G	102,4;104;104	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5736	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3179	180.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2100	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1818	114.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	577	577	C	161	C,T	148,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	412	414	GAA	258;258;261	G;A;A	247;248;250	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	S46G	NONSYN	136	138	AGC	436	438	GGC	233;232;231	G;G,T;C	225;220,1;221	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	E48G	NONSYN	142	144	GAA	442	444	GGA	237;235;238	G;G,A;A	226;220,1;226	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	T87A	NONSYN	259	261	ACT	559	561	GCT	229;229;227	G;C;T	211;215;213	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	T89S	NONSYN	265	267	ACC	565	567	AGC	231;230;232	A;G;C,T	215;217;214,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	.	MULTIPLE	358	359	AA	657	658	CG	243;240	C;G	230;224	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	.	MULTIPLE	361	362	GA	660	662	CAG	238;240;238	C;A;G	227;228;228	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	664	666	AAA	239;234;234	A;A;A	229;221;220	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	K143E	NONSYN	427	429	AAA	727	729	GAA	261;262;261	G,A;A;A	240,1;244;243	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	751	753	GCA	271;268;267	G;C;A	250;251;245	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	A215T	NONSYN	643	645	GCT	943	945	ACT	226;224;223	A;C;T	216;215;214	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	I218M	NONSYN	652	654	ATA	952	954	ATG	222;224;224	A;T;G	215;213;212	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1066	1068	GCA	225;226;234	G;C;A	216;215;223	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1069	1071	ACG	230;230;228	A;C,T;G	216;217,1;220	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1072	1074	GGG	228;230;230	G;G;G,A	221;222;221,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1075	1077	GTT	229;229;231	G;T;TAA,TA	219;215;221,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1135	1137	GTA	262;263;261	G;T;A	245;247;248	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1174	1176	ACT	254;253;252	A;C;T	235;240;237	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1180	1182	GAT	252;250;245	G,T;A;T	235,1;235;234	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1192	1194	CAC	253;246;246	C;A;C	245;237;240	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	1	SNP	p	G120K	1	.	.	358	360	AAG	657	659	CGG	243;240;238	C;G;G	230;224;224	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	1	SNP	p	A121D	1	.	.	361	363	GAC	660	663	CGC	238;238;241	C;G;C	227;228;229	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3080	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1491	205.3	1	SNP	p	D121N	0	.	.	361	363	GAC	660	663	CGC	238;238;241	C;G;C	227;228;229	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11734	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4945	236.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2007	2009	CAT	252;249;249	C;A;T	244;239;240	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1264	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1086	115.8	1	SNP	p	V57M	1	.	.	169	171	ATG	508	510	ATG	248;246;247	A;T;G	239;233;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
